TY - JOUR AU - Breuer, W. AU - Shvartsman, M. AU - Cabantchik, Z. I. PY - 2008 DA - 2008// TI - Intracellular labile iron JO - Int J Biochem Cell Biol VL - 40 UR - https://doi.org/10.1016/j.biocel.2007.03.010 DO - 10.1016/j.biocel.2007.03.010 ID - Breuer2008 ER - TY - JOUR AU - Hochstrasser, H. AU - Tomiuk, J. AU - Walter, U. AU - Behnke, S. AU - Spiegel, J. AU - Krüger, R. PY - 2005 DA - 2005// TI - Functional relevance of ceruloplasmin mutations in Parkinson’s disease JO - FASEB J VL - 19 ID - Hochstrasser2005 ER - TY - JOUR AU - Olivieri, S. AU - Conti, A. AU - Iannaccone, S. AU - Cannistraci, C. V. AU - Campanella, A. AU - Barbariga, M. PY - 2011 DA - 2011// TI - Ceruloplasmin oxidation, a feature of Parkinson’s disease CSF, inhibits ferroxidase activity and promotes cellular iron retention JO - J Neurosci VL - 31 UR - https://doi.org/10.1523/JNEUROSCI.3768-11.2011 DO - 10.1523/JNEUROSCI.3768-11.2011 ID - Olivieri2011 ER - TY - JOUR AU - Ayton, S. AU - Lei, P. AU - Duce, J. A. AU - Wong, B. X. AU - Sedjahtera, A. AU - Adlard, P. A. PY - 2013 DA - 2013// TI - Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease JO - Ann Neurol VL - 73 UR - https://doi.org/10.1002/ana.23817 DO - 10.1002/ana.23817 ID - Ayton2013 ER - TY - JOUR AU - Boll, M. C. AU - Sotelo, J. AU - Otero, E. AU - Alcaraz-Zubeldia, M. AU - Rios, C. PY - 1999 DA - 1999// TI - Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson’s disease JO - Neurosci Lett VL - 265 UR - https://doi.org/10.1016/S0304-3940(99)00221-9 DO - 10.1016/S0304-3940(99)00221-9 ID - Boll1999 ER - TY - JOUR AU - Hochstrasser, H. AU - Bauer, P. AU - Walter, U. AU - Behnke, S. AU - Spiegel, J. AU - Csoti, I. PY - 2004 DA - 2004// TI - Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease JO - Neurology VL - 63 UR - https://doi.org/10.1212/01.WNL.0000144276.29988.C3 DO - 10.1212/01.WNL.0000144276.29988.C3 ID - Hochstrasser2004 ER - TY - JOUR AU - Friedman, A. AU - Galazka-Friedman, J. PY - 2012 DA - 2012// TI - The history of the research of iron in Parkinsonian substantia nigra JO - J Neural Transm VL - 119 UR - https://doi.org/10.1007/s00702-012-0894-8 DO - 10.1007/s00702-012-0894-8 ID - Friedman2012 ER - TY - JOUR AU - Cabantchik, Z. I. AU - Munnich, A. AU - Youdim, M. B. AU - Devos, D. PY - 2013 DA - 2013// TI - Regional siderosis: a new challenge for iron chelation therapy JO - Front Pharmacol VL - 4 UR - https://doi.org/10.3389/fphar.2013.00167 DO - 10.3389/fphar.2013.00167 ID - Cabantchik2013 ER - TY - JOUR AU - Devos, D. AU - Moreau, C. AU - Devedjian, J. C. AU - Kluza, J. AU - Petrault, M. AU - Laloux, C. PY - 2014 DA - 2014// TI - Targeting chelatable iron as a therapeutic modality in Parkinson’s disease JO - Antioxid Redox Signal VL - 21 UR - https://doi.org/10.1089/ars.2013.5593 DO - 10.1089/ars.2013.5593 ID - Devos2014 ER - TY - JOUR AU - Schosinsky, K. H. AU - Lehmann, H. P. AU - Beeler, M. F. PY - 1974 DA - 1974// TI - Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride JO - Clin Chem VL - 20 ID - Schosinsky1974 ER - TY - JOUR AU - Martınez-Subiela, S. AU - Tecles, F. AU - Ceron, J. J. PY - 2007 DA - 2007// TI - Comparison of two automated spectrophotometric methods for ceruloplasmin measurement in pigs JO - Res Vet Sci VL - 83 UR - https://doi.org/10.1016/j.rvsc.2006.10.011 DO - 10.1016/j.rvsc.2006.10.011 ID - Martınez-Subiela2007 ER - TY - JOUR AU - Siotto, M. AU - Pasqualetti, P. AU - Marano, M. AU - Squitti, R. PY - 2014 DA - 2014// TI - Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson’s disease and in hepatic encephalopathy JO - J Neural Transm VL - 121 UR - https://doi.org/10.1007/s00702-014-1196-0 DO - 10.1007/s00702-014-1196-0 ID - Siotto2014 ER -